Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study

Objective: To investigate longitudinal changes in the blood concentration of fibroblast growth factor 23 (FGF23) from midlife to late life and their major predictors in the general population. Patients and Methods: In 14,444 participants of the Atherosclerosis Risk in Communities Study, we analyzed...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Junichi Ishigami, MD, MPH, Yasuyuki Honda, MD, Amy B. Karger, MD, PhD, Josef Coresh, MD, PhD, Elizabeth Selvin, PhD, MPH, Pamela L. Lutsey, PhD, MPH, Kunihiro Matsushita, MD, PhD
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2022-06-01
Serija:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online pristup:http://www.sciencedirect.com/science/article/pii/S2542454822000133
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items